Physician

Abhay Singh, MD, MPH

According to 2025 Medicare claims, Abhay Singh, MD, MPH (NPI: 1659789634) practices hematology/oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Singh is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 80 traditional Medicare patients, billed 288 HCPCS/CPT codes, and received $20,624 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 457 prescription claims across 61 beneficiaries totaling $1,763,431 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 11 records totaling $1,179,788. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,360 to $1,763,431. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$17K$35K2021 Medicare payment: $12,933 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $33,667 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $34,750 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $20,624 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202139147$12,933
202294409$33,667
202381422$34,750
202480288$20,624

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$882K$1.8M2015 Drug cost: $1,360 (USD; Tot_Drug_Cst)2016 Drug cost: $1,191 (USD; Tot_Drug_Cst)2018 Drug cost: $15,014 (USD; Tot_Drug_Cst)2019 Drug cost: $72,991 (USD; Tot_Drug_Cst)2020 Drug cost: $9,604 (USD; Tot_Drug_Cst)2021 Drug cost: $51,320 (USD; Tot_Drug_Cst)2022 Drug cost: $953,714 (USD; Tot_Drug_Cst)2023 Drug cost: $1,189,082 (USD; Tot_Drug_Cst)2024 Drug cost: $1,763,431 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152443$1,360
20161223$1,191
2017N/RN/RN/R
201841107$15,014
201967205$72,991
20201645$9,604
20213067$51,320
202269411$953,714
202358396$1,189,082
202461457$1,763,431

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1619$103
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1765$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3061$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4573$50

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate722,095$1,284,608
VenclextaVenetoclax16445$14,898
AcyclovirAcyclovir873,770$1,189
HydroxyureaHydroxyurea241,252$578
Pantoprazole SodiumPantoprazole Sodium17750$126

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$571Rigel Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.3$1,179,217Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abhay Singh, MD, MPH?

Tedicare shows public-source Medicare data for Abhay Singh, MD, MPH (NPI 1659789634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhay Singh, MD, MPH have ACO affiliation data?

Abhay Singh, MD, MPH is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Abhay Singh, MD, MPH?

Abhay Singh, MD, MPH is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Abhay Singh, MD, MPH have Open Payments data?

Abhay Singh, MD, MPH has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.